Potency assays and biomarkers for cell-based advanced therapy medicinal products

Potency assays and biomarkers for cell-based advanced therapy medicinal products

Advanced Therapy Medicinal Products (ATMPs) based on somatic cells expanded in vitro, with or without genetic modification, is a rapidly growing area of drug development, even more so following the marketing approval of several such products. ATMPs are produced according to Good Manufacturing Practi...

Full description

Bibliographic Details
Main Authors: Chiara Capelli, Carolina Cuofano, Chiara Pavoni, Simona Frigerio, Daniela Lisini, Sara Nava, Michele Quaroni, Valentina Colombo, Francesco Galli, Svetlana Bezukladova, Paola Panina-Bordignon, Giuseppe Gaipa, Patrizia Comoli, Giulio Cossu, Gianvito Martino, Andrea Biondi, Martino Introna, Josée Golay
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
advanced therapy medicinal product (ATMP)
potency
CAR (chimeric antigen receptor)
T cell therapy
stem cell
tissue regeneration
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186224/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1186224/full

Similar Items